Skip to content

Kodiak Sciences Inc KOD Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
-$9.25M-57.0%
Vera Therapeutics logo
Vera TherapeuticsVERA
-$437K+90.9%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$20.77M+9,805%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
-$5.05M-40.4%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-$7.21M+38.3%
Roivant Sciences logo
Roivant SciencesROIV
$63.23M

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's change in accrued liabilities?
Kodiak Sciences Inc (KOD) reported change in accrued liabilities of $4.56M in Q1 2026.
How has Kodiak Sciences Inc's change in accrued liabilities changed year-over-year?
Kodiak Sciences Inc's change in accrued liabilities increased by 93.5% year-over-year, from $2.36M to $4.56M.
What is the long-term trend for Kodiak Sciences Inc's change in accrued liabilities?
Over 2 years (2022 to 2025), Kodiak Sciences Inc's change in accrued liabilities has grown at a 103.2% compound annual growth rate (CAGR), from -$2.25M to $9.28M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.